- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 1 residues within 4Å:- Chain C: N.137
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain C: N.212
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain C: A.448, N.449
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain C: N.713
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain C: D.727, N.738, T.740
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain C: S.785, N.787
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain C: A.932, A.933, N.936
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain C: V.1192, N.1193, M.1197, P.1206
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain C: N.695, Y.759
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain C: E.646, V.647, N.648
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain D: A.448, N.449
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain D: I.673, N.675
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain D: E.646, V.647, N.648
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain D: H.693, N.695, Y.759
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain D: S.785, V.786, N.787
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain C: K.1014
- Chain D: V.1222, N.1223
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain E: A.932, A.933, N.936, G.940
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain E: L.62, N.63, Q.288
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain E: L.159, V.211, N.212
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain E: P.446, N.449
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain E: E.646, V.647, N.648
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain E: N.713
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain E: N.787
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain E: V.1192, N.1193, M.1197
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain E: V.1222, N.1223
Ligand excluded by PLIP- 3 x 8Z9: Sapienic acid(Non-covalent)
8Z9.32: 16 residues within 4Å:- Chain C: M.372, L.375, M.376, I.379, A.381, A.391, I.394, Y.395, I.402, L.441, L.603
- Chain D: V.415, D.416, N.421, L.422, G.423
12 PLIP interactions:4 interactions with chain D, 8 interactions with chain C- Hydrophobic interactions: D:V.415, D:N.421, C:L.375, C:I.379, C:A.381, C:I.394, C:I.402, C:L.441, C:L.603
- Hydrogen bonds: D:L.422, D:G.423, C:Y.395
8Z9.33: 17 residues within 4Å:- Chain D: F.370, M.372, L.375, M.376, I.379, A.381, F.384, A.391, I.394, Y.395, L.603, L.605
- Chain E: V.415, D.416, N.421, L.422, G.423
13 PLIP interactions:9 interactions with chain D, 4 interactions with chain E- Hydrophobic interactions: D:F.370, D:L.375, D:L.375, D:I.379, D:A.381, D:F.384, D:I.394, D:L.605, E:V.415
- Hydrogen bonds: D:Y.395, E:N.421, E:L.422, E:G.423
8Z9.43: 12 residues within 4Å:- Chain C: N.421, L.422, G.423
- Chain E: F.370, M.372, L.375, A.391, Y.395, I.402, L.441, L.603, L.605
10 PLIP interactions:7 interactions with chain E, 3 interactions with chain C- Hydrophobic interactions: E:F.370, E:L.375, E:I.402, E:L.441, E:L.603, E:L.605, C:N.421
- Hydrogen bonds: E:Y.395, C:L.422, C:G.423
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Human polyclonal Fab model with polyalanine backbone - Heavy chain: AB
Spike protein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
JD
AE
B
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 8Z9: Sapienic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bangaru, S. et al., Structural mapping of antibody landscapes to human betacoronavirus spike proteins. Sci Adv (2022)
- Release Date
- 2022-05-04
- Peptides
- Human polyclonal Fab model with polyalanine backbone - Heavy chain: AB
Spike protein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
JD
AE
B